[Effect of genetic polymorphisms on functioning of a permanent vascular access in patients on dialysis].

Thromboses and stenoses of permanent vascular access appear to be a serious hazard for patients with end-stage kidney disease on programmed haemodialysis. Relapses of these pathological conditions are the cause of repeated hospitalization, secondary surgical interventions and may eventually lead to impossibility of carrying out procedures of haemodialysis. Often, vascular access dysfunction occurs for no apparent reason, thus underlying the importance of studies aimed at revealing additional factors of intravascular thrombogenesis and neointimal formation in a vascular access, including the works dedicated to studying genetic predictors of the development of the above-mentioned complications. The authors examined herein the role of polymorphisms of the genes of endothelin-1 (END-1), nitric oxide synthase-3 (NOS-3), angiotensinogen-2 (AGT-2), angiotensinogen-1 (AGT-1), angiotensinogen 2 receptor type 1 (AGTR1), mitochondrial superoxide dismutase-2 (SOD-2), catalase (CAT) superoxide dismutase-1 (SOD-1) and angiotensin converting enzyme (ACE) in the functional state of permanent vascular access in patients on dialysis. The obtained results demonstrated direct cause-and-effect relationships between polymorphisms lys-198 asn in the END-1 gene, C60T, T58C in the SOD-2 gene and the function of vascular access. The presence of END-1 gene lys-198 asn polymorphism in a homozygous state (allele 1) was associated with a high risk of an unsatisfactory condition of permanent vascular access (p=0.019).

[1]  Wu-chang Yang,et al.  Association of Genetic Polymorphisms of Renin–Angiotensin–Aldosterone System-Related Genes with Arterio-Venous Fistula Malfunction in Hemodialysis Patients , 2016, International journal of molecular sciences.

[2]  E. Uz,et al.  Manganese superoxide dismutase, glutathione peroxidase and catalase gene polymorphisms and clinical outcomes in acute kidney injury , 2016, Renal failure.

[3]  C. Yen,et al.  Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients , 2016, Oxidative medicine and cellular longevity.

[4]  E. Uz,et al.  The relationship between serum fetuin a levels and fetuin gene polymorphism in hemodialysis patients , 2015 .

[5]  A. Besarab,et al.  Novel Therapeutic Paradigms to Treat Hemodialysis Access Dysfunction , 2014 .

[6]  Timmy Lee,et al.  Genetic Causation of Neointimal Hyperplasia in Hemodialysis Vascular Access Dysfunction , 2012, Seminars in dialysis.

[7]  Wu-chang Yang,et al.  Functional polymorphisms in matrix metalloproteinases-1, -3, -9 are associated with arteriovenous fistula patency in hemodialysis patients. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[8]  C. Doig,et al.  Risk factors associated with patency loss of hemodialysis vascular access within 6 months. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[9]  J. Hinz,et al.  Impact of endothelin-1 Lys198Asn polymorphism on coronary artery disease and endorgan damage in hypertensives , 2008, Coronary artery disease.

[10]  M. Haberal,et al.  Endothelial Nitric Oxide Synthase Gene Intron 4 (VNTR) Polymorphism and Vascular Access Graft Thrombosis , 2007, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[11]  K. Abreo,et al.  Tumor Necrosis Factor-a -308 Gene Polymorphism Is Associated with Synthetic Hemodialysis Graft Failure , 2003, Journal of Investigative Medicine.